Literature DB >> 18716483

Lung insufflation capacity in neuromuscular disease.

John Robert Bach1, Kedar Mahajan, Bethany Lipa, Lou Saporito, Miguel Goncalves, Eugene Komaroff.   

Abstract

OBJECTIVE: To compare maximal passive lung insufflation capacity (LIC) with lung inflation by air stacking (to maximum insufflation capacity [MIC]) and with vital capacity (VC); to explore relationships between these variables that correlate with glottic function and cough peak flows (CPF); to demonstrate the effect of routine inflation therapy on LIC and MIC; and to determine the relative importance of lung inflation therapy as a function of disease severity.
DESIGN: Case series of 282 consecutive neuromuscular disease (NMD) clinic patients 7 yrs and older with VC <70% of the predicted normal value. All cooperative patients meeting these criteria were prescribed thrice-daily air stacking and/or maximal passive lung insufflation to pressures of 40-80 cm H2O, and they underwent measurements of VC, MIC, LIC, and unassisted and assisted CPF on every visit.
RESULTS: Means +/- standard deviations for VC, MIC, and LIC were 1131 +/- 744, 1712 +/- 926, and 2069 +/- 867 ml, respectively, and, for unassisted and assisted CPF, they were 2.5 +/- 2.0 and 4.3 +/- 2.2 liters/sec, respectively, with all differences statistically significant (P < 0.001). MIC minus VC correlated inversely with LIC minus MIC (P = 0.01) and, therefore, with glottic function. Both MIC and LIC increased with practice (P < 0.001). Increases in LIC but not MIC over VC were greatest for patients with the lowest VC (P < 0.05). There were no complications of lung mobilization therapy.
CONCLUSIONS: Passive lung insufflation can distend the lungs of patients with NMD significantly greater than air stacking, particularly when glottic and bulbar-innervated muscle dysfunction is severe. LIC, MIC, and VC measurements permit quantifiable assessment of glottic integrity and, therefore, bulbar-innervated muscle function for patients with NMD. The patients who benefit the most from insufflation therapy are those who have the lowest VC.

Entities:  

Mesh:

Year:  2008        PMID: 18716483     DOI: 10.1097/PHM.0b013e31817fb26f

Source DB:  PubMed          Journal:  Am J Phys Med Rehabil        ISSN: 0894-9115            Impact factor:   2.159


  10 in total

Review 1.  Noninvasive respiratory management of high level spinal cord injury.

Authors:  John R Bach
Journal:  J Spinal Cord Med       Date:  2012-03       Impact factor: 1.985

2.  Effects of Expiratory Muscle Training and Air Stacking on Peak Cough Flow in Individuals with Parkinson's Disease.

Authors:  Alvaro Reyes; Adrián Castillo; Javiera Castillo
Journal:  Lung       Date:  2019-11-12       Impact factor: 2.584

3.  Lung Insufflation Capacity with a New Device in Amyotrophic Lateral Sclerosis: Measurement of the Lung Volume Recruitment in Respiratory Therapy.

Authors:  Keisuke Yorimoto; Yosuke Ariake; Takako Saotome; Madoka Mori-Yoshimura; Tadashi Tsukamoto; Yuji Takahashi; Yoko Kobayashi
Journal:  Prog Rehabil Med       Date:  2020-05-26

4.  Artificial external glottic device for passive lung insufflation.

Authors:  Dong Hyun Kim; Seong-Woong Kang; Yoon Ghil Park; Won Ah Choi; Hye Ree Lee
Journal:  Yonsei Med J       Date:  2011-11       Impact factor: 2.759

5.  Pneumothorax as a complication of lung volume recruitment.

Authors:  Erik J A Westermann; Maurice Jans; Michael A Gaytant; John R Bach; Mike J Kampelmacher
Journal:  J Bras Pneumol       Date:  2013 May-Jun       Impact factor: 2.624

6.  Air stacking: effects on pulmonary function in patients with spinal muscular atrophy and in patients with congenital muscular dystrophy.

Authors:  Tanyse Bahia Carvalho Marques; Juliana de Carvalho Neves; Leslie Andrews Portes; João Marcos Salge; Edmar Zanoteli; Umbertina Conti Reed
Journal:  J Bras Pneumol       Date:  2014-10       Impact factor: 2.624

7.  Short-term effect of air stacking and mechanical insufflation-exsufflation on lung function in patients with neuromuscular diseases.

Authors:  Esther S Veldhoen; Femke Vercoelen; Leandra Ros; Laura P Verweij-van den Oudenrijn; Roelie M Wösten-van Asperen; Erik Hj Hulzebos; Bart Bartels; Michael A Gaytant; Kors van der Ent; W Ludo van der Pol
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

8.  Routine lung volume recruitment in boys with Duchenne muscular dystrophy: a randomised clinical trial.

Authors:  Sherri L Katz; Jean K Mah; Hugh J McMillan; Craig Campbell; Vid Bijelić; Nick Barrowman; Franco Momoli; Henrietta Blinder; Shawn D Aaron; Laura C McAdam; The Thanh Diem Nguyen; Mark Tarnopolsky; David F Wensley; David Zielinski; Louise Rose; Nicole Sheers; David J Berlowitz; Lisa Wolfe; Doug McKim
Journal:  Thorax       Date:  2022-03-02       Impact factor: 9.102

Review 9.  Noninvasive Respiratory Management of Patients With Neuromuscular Disease.

Authors:  John R Bach
Journal:  Ann Rehabil Med       Date:  2017-08-31

Review 10.  Respiratory Involvement in Patients with Neuromuscular Diseases: A Narrative Review.

Authors:  Athanasios Voulgaris; Maria Antoniadou; Michalis Agrafiotis; Paschalis Steiropoulos
Journal:  Pulm Med       Date:  2019-12-26
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.